• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Michael Washbrook
Michael Washbrook
Michael Washbrook

Michael Washbrook

Partner

  • London UK
  • Dublin Ireland
Contact Me Today
+44 20 7300 4274
vCard
Email me Call me
Featured award

Legal 500 UK 2026

Next generation partner in the intellectual property: patents (contentious and non-contentious) category.

Scroll to featured award

Mike is a partner in the Patents & Innovation group who specialises in Tech and Life sciences patent litigation. Mike has advised a wide range of clients from multinational companies to SMEs on patent matters across a variety of technologies including pharmaceuticals, medical devices and telecommunications. He has experience of advising clients in relation to multinational litigation across Europe, and in European Patent Office proceedings. Mike also has a particular focus on the relationship between intellectual property rights and competition law.

Expertise

Services and Groups

Competition, EU & trade
Patents & innovation

Sectors

Technology, media & communications
Life sciences & healthcare
Medical devices

Patent Perspective Quick Listens

A UPC and European patent litigation podcast.

Listen now

CV

Since 2021 Partner, Taylor Wessing
2020 - 2021 Senior counsel, Taylor Wessing
2016 - 2020 Senior Associate, Taylor Wessing
2011 - 2016 Associate, Taylor Wessing
2009 - 2011 Trainee solicitor, Taylor Wessing
2012 Post Graduate Diploma, Intellectual Property Law and Practice, University of Oxford
2011 Admitted to the Bar, England and Wales
2009 Legal Practice Course, Nottingham Law School
2008 Graduate Diploma, Law, Nottingham Law School
2007 BSc degree, Biological Sciences, University of Sheffield

Career

Since 2021 Partner, Taylor Wessing
2020 - 2021 Senior counsel, Taylor Wessing
2016 - 2020 Senior Associate, Taylor Wessing
2011 - 2016 Associate, Taylor Wessing
2009 - 2011 Trainee solicitor, Taylor Wessing

Education

2012 Post Graduate Diploma, Intellectual Property Law and Practice, University of Oxford
2011 Admitted to the Bar, England and Wales
2009 Legal Practice Course, Nottingham Law School
2008 Graduate Diploma, Law, Nottingham Law School
2007 BSc degree, Biological Sciences, University of Sheffield

Additional languages

English

Awards

Legal 500 UK 2026

Featured

Next generation partner in the intellectual property: patents (contentious and non-contentious) category.

Legal 500 UK 2025

Next generation partner

Managing Intellectual Property – IP Stars 2024

Patent star

Managing Intellectual Property IP Stars

Rising Star 2021

Rising star

Experience

A telecommunications company

A telecommunications company on FRAND issues associated with the enforcement of standard essential patents.

Michael Washbrook

A pharmaceutical manufacturer

A pharmaceutical manufacturer on EPO opposition proceedings to revoke patents relating to a monoclonal antibody.

Michael Washbrook

A pharmaceutical manufacturer

A pharmaceutical manufacturer on the pan-European litigation associated with launching a generic version of a chemotherapy drug.

Michael Washbrook

An agrochemicals manufacturer

An agrochemicals manufacturer in High Court litigation concerning the validity of patent relating to the microencapsulation of pesticides.

Michael Washbrook

A telecommunications company

A telecommunications company in High Court litigation concerning the validity and infringement of standard essential telecommunications patents.

Michael Washbrook

A pharmaceutical manufacturer

A pharmaceutical manufacturer in High Court litigation concerning a competition law based claim for damages relating to the heartburn medicine Gaviscon.

Michael Washbrook
Louisa Penny

Michael's news & insights

View Michael's insights
UPC
Click here to find out more
UPC

The UK and the Unified Patent Court, two years in - the UPC’s long-arm jurisdiction over the UK

4 June 2025

by Dr Paul England and Michael Washbrook

Patent Perspectives Quick Listens Open podcast
Patent Perspectives Quick Listens

Episode 7 - Obtaining documentary evidence in the UPC - a look at Rule 190 of the Rules of Procedure

In this episode Paul England is joined by Lydia Birch, Anja Lunze and Michael Washbrook

15 April 2025

by multiple authors

4 of 10 Podcasts

Click here to find out more
Patent Perspectives Quick Listens - Episode 4 Open podcast
Patent Perspectives Quick Listens

Episode 4: SEPs and FRAND developments in the Unified Patent Court (UPC)

In this episode Paul England is joined by Geert Theuws, Xuyang Zhu, Mike Washbrook and Phillip Rektorschek.

3 March 2025

by multiple authors

7 of 10 Podcasts

Click here to find out more
View Michael's insights

Related news & insights

Overhead view of scientist using centrifuge machine
Life sciences & healthcare

Research and innovation as a competitive advantage – Legal framework for Life Sciences made in Europe

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Patterned pills
Life sciences & healthcare

Life Sciences Made in Europe – The European Commission’s Life Sciences Strategy 2030

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Blood samples
Life sciences & healthcare

Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices

23 January 2026
Briefing

by Irina Rebin and Daniel Dietrich

Click here to find out more
Escalator
Consumer & retail

Consumer and Retail in the News

23 January 2026
Quick read

by multiple authors

Click here to find out more
Low Angle View Of Flags Waving
Logistics & transport

EU Inc.: Founders and companies with expansion plans must now think strategically

23 January 2026
Quick read

by Dr. Benedikt Groh and Fritz Krings

Click here to find out more
Technology, media & communications

UK Online Safety Act fees regime kicks off – initial notifications due by 11 April 2026

22 January 2026
Quick read

by Debbie Heywood

Click here to find out more
Working Data Centre
Technology, media & communications

Ofcom's guidance on online safety for women and girls and UK government strategy

22 January 2026
Briefing

by Debbie Heywood

Click here to find out more
Office facade reflection
Life sciences & healthcare

Advising Nuclera on its extended Series C funding to US$87 million

22 January 2026

by Ross McNaughton and Oli Denne

Click here to find out more
Robotic hand
Data & cyber

The Data Act – Important obligations for cloud and edge services

22 January 2026
Briefing

by Dr. Paul Voigt, Lic. en Derecho, CIPP/E and Richard Gläser

Click here to find out more
Server farm
Technology, media & communications

Ofcom investigates X's Grok as scrutiny of deepfakes and nudification tools increases

22 January 2026
In-depth analysis

by Debbie Heywood

Click here to find out more
View all insights

Related people

UK
Global
Clare Reynolds

Clare Reynolds

Partner

London
+44 207 300 7074
Email me
View profile
Amanda Ebbutt

Amanda Ebbutt

Partner

London
+44 20 7300 7130
Email me
View profile
Christopher Thornham

Chris Thornham

Partner

London
+44 20 7300 4817
Email me
View profile
Kim Wedral

Kim Wedral

Partner

Cambridge
+44 1223 446 400
Email me
View profile
Lydia Birch

Lydia Birch

Senior Counsel

London
+44 20 7300 7000
Email me
View profile
Ed Vickers

Edward Vickers

Senior Counsel

London
+44 20 7300 7000
Email me
View profile
Tom Foster

Tom Foster

Partner

London
+44 20 7300 4954
Email me
View profile
Andrew Payne

Andrew Payne

Partner

London
+44 207 300 7145
Email me
View profile
Person Placeholder Image

Eve Dunne

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Dr Katie Atkinson

Dr Katie Atkinson

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Full team
Christian Dekoninck

Christian Dekoninck

Partner

Brussels
+32 2 3202 251
Email me
View profile
Justyna Ostrowska

Justyna Ostrowska-Krupa

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Anne-Sophie van Beek

Anne-Sophie van Beek

Associate

Eindhoven
+31 88 02 43 131
Email me
View profile
Pauline Albouy

Pauline Albouy

Senior Associate

Paris
+33 1 72 74 03 33
Email me
View profile

Daisy Termeulen

Counsel

Amsterdam
+31 88 02 43 039
Email me
View profile
Nora E. Wessendorf

Dr. Nora E. Wessendorf, LL.M. (Washington)

Salary Partner

Duesseldorf
San Francisco
+49 211 8387 0
Email me
View profile
Daniel Dietrich

Daniel Dietrich

Associate

Munich
+49 89 21038 0
Email me
View profile
Rebin Irina

Irina Rebin

Salary Partner

Munich
+49 89 21038 0
Email me
View profile
Julie Chiu

Julie Chiu

Senior Counsel

London
+44 20 7300 7000
Email me
View profile
Geert Theuws

Geert Theuws

Counsel

Eindhoven
+31 88 02 43 197
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing